Form 4 for GENB Generate Biomedicines, Inc.
Accepted 2026-03-02 00:00:00 ET · period of report 2026-02-26 · accession 0001193125-26-085872 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-02 | 2026-03-02 | GENB | Mendillo Jane L | Dir | P - Purchase | $16.00 | +1,500 | 1,500 | New | +$24.0K |
| D | 2026-03-02 | 2026-02-26 | GENB | Mendillo Jane L | Dir | A - Grant | $0.00 | +29.6K | 29.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-02 | P | A | 1,500 | $16.00 | 1,500 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-02-26 | A | A | 29,561 | $0.00 | 29,561 | D | $16.00 · — to 2036-02-25 | 29,561 Common Stock | (F1) The shares underlying this option shall vest in full on February 19, 2027, subject to the Reporting Person's continued service on such vesting date. |